AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27068399
Drug: Darunavir/ritonavir (800/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir (800/100 mg)
Trial: 20105163
Drug: GR1 (1‐hour,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR1 (1‐hour, 50‐g glucose screen +/‐ 3‐hour, 100‐g OGTT)
Trial: 20105163
Drug: GR2 (50‐g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR2 (50‐g GS +/‐ 2‐hour, 75‐g OGTT)
Trial: 20105163
Drug: GR3 (2‐hour,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR3 (2‐hour, 75‐g OGTT)
Trial: 12574898
Drug: Colchicine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1.5 mg/day) for 1 month
Trial: 1731034
Drug: Daily maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily maintenance sodium (3 to 4 mEq of sodium per kilogram per day)
Trial: 1731034
Drug: Salt restriction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salt restriction (no sodium supplement other than with treatments such as transfusion)
Trial: 6376301
Drug: Tetrachlorodecaoxide (TCDO)
RxNorm normalized name: Tetrachlorodecaoxide
DrugBank: Tetrachlorodecaoxide (DB05389)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrachlorodecaoxide (TCDO) in a water solution containing glycerin
Trial: 29450890
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate (ESL) 1600 mg once daily
Trial: 29450890
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate (ESL) 1200 mg once daily
Trial: 22945623
Drug: 1000‐mg naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000‐mg naltrexone implant and oral placebo (NI+OP group; 102 patients)
Trial: 22945623
Drug: Placebo implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo implant and 50‐mg oral naltrexone hydrochloride (PI+ON group; 102 patients)
Trial: 22945623
Drug: Placebo implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo implant and oral placebo (PI+OP group; 102 patients)
Trial: 10085276
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg SQV/200 mg RTV
Trial: 10085276
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg SQV
Trial: 27085785
Drug: Alanine aminotransferase
RxNorm normalized name: Alanine aminotransferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alanine aminotransferase (ALT) levels, adjusted for every standard deviation increase (13.2 U/L)
Trial: 27085785
Drug: γ-glutamyl transferase
RxNorm normalized name: 5-L-Glutamyl-L-cysteinylglycine
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ-glutamyl transferase (GGT) >70 U/L
Trial: 27085785
Drug: GGT >70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GGT >70 U/L
Trial: 19843837
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with at least one unexplained medication discrepancy
Trial: 19843837
Drug: Patients prescribed
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients prescribed 5 or more drugs at discharge from the ED
Trial: 2216622
Drug: Single-dose surfactant
RxNorm normalized name: surfactant protein-D homotrimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose surfactant (100 mg/kg of bovine surfactant)
Trial: 2216622
Drug: Multiple-dose surfactant
RxNorm normalized name: surfactant protein-D homotrimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose surfactant (100 mg/kg of bovine surfactant, eligible for up to three additional doses)
Trial: 30430605
Drug: Emricasan 25
RxNorm normalized name: Emricasán
DrugBank: Emricasan (DB05408)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emricasan 25 mg twice daily
Trial: 25468170
Drug: 6 weeks
RxNorm normalized name: perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 6 weeks of antibiotic treatment
Trial: 25468170
Drug: 12 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12 weeks of antibiotic treatment
Trial: 23321318
Drug: Telaprevir (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telaprevir (750 mg every 8h) with PegIFN-α-2a (180 μg/week) and ribavirin (1000-1200 mg/day) for 48 weeks
Trial: 23321318
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with PegIFN-α-2a (180 μg/week) and ribavirin (1000-1200 mg/day) for 48 weeks
Trial: 17629162
Drug: Daflon (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon (500 mg twice/daily for six months)
Trial: 17629162
Drug: Placebo (vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vitamin pill)
Trial: 362213
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and glucose
Trial: 23454402
Drug: Desmopressin 50
RxNorm normalized name: desmopressin acetate 55.3 MCG (desmopressin 50 MCG) Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin 50 μg
Trial: 23454402
Drug: Desmopressin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin 75 μg
Trial: 22142351
Drug: Carvedilol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (80 mg, once daily for 4 weeks)
Trial: 22142351
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg, once daily for 4 weeks)
Trial: 18647845
Drug: Acetaminophen, ibuprofen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen, ibuprofen, and/or 4% lidocaine gel
Trial: 12874748
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 220 mg per day for 6 weeks
Trial: 12874748
Drug: Placebo (dummy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (dummy pill)
Trial: 9128016
Drug: Low-dose prostaglandin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prostaglandin E1 (PGE1) at a rate of 0.2 microgram.kg‐1.min‐1 throughout surgery
Trial: 3555016
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (slow‐release aspirin and dipyridamole)
Trial: 22924259
Drug: Treatment according
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment according to guidelines (British National Formulary - BNF, and Senford Guide)
Trial: 11790467
Drug: Ordinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary treatment
Trial: 17032157
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy in addition to treatment as usual
Trial: 10669153
Drug: Fluvastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin therapy for 4 weeks
Trial: 9322469
Drug: Ultrasound (US)
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound (US) guidance with 20 mL bupivacaine 0.5%
Trial: 9322469
Drug: Nerve stimulator
RxNorm normalized name: nerve stimulator device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve stimulator (NS) with 20 mL bupivacaine 0.5%
Trial: 30612134
Drug: Diclofenac Sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac Sodium (75 mg)
Trial: 28580504
Drug: Emotion-Focused Cognitive-Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emotion-Focused Cognitive-Behavioral Therapy (ECBT)
Trial: 28580504
Drug: Traditional Cognitive-Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Cognitive-Behavioral Therapy (CBT)
Trial: 26322555
Drug: Caffeine (∼
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (∼ 5 mg · kg(‐1) body weight)
Trial: 22913676
Drug: LCAF with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCAF with concurrent chemotherapy (LCAF + CT)
Trial: 19969511
Drug: Preoperative radio-chemotherapy
RxNorm normalized name: Valerianae radix
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative radio-chemotherapy (RCT)
Trial: 17391930
Drug: donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 5 mg for 6 weeks then donepezil 10 mg for six weeks
Trial: 15359055
Drug: Advanced practice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced practice nursing support (telephone calls from an APN twice in the first week and weekly for 4 weeks)
Trial: 11260420
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of VP and Qa monitoring
Trial: 8004731
Drug: Intubation following
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intubation following induction of anaesthesia with thiopentone 5 mg.kg‐1 and succinylcholine 2 mg.kg‐1
Trial: 2537830
Drug: Combined vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vaccine (C) against yellow fever and measles
Trial: 2537830
Drug: Yellow fever
RxNorm normalized name: yellow fever live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yellow fever vaccine only (A)
Trial: 2537830
Drug: Measles vaccine
RxNorm normalized name: Measles vaccine
DrugBank: Measles virus vaccine live attenuated (DB10315)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles vaccine only (B)
Trial: 15231512
Drug: Anti-TNF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF therapy (D2E7, adalimumab, Humira)
Trial: 30828762
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with diuretics and vasodilators
Trial: 30828762
Drug: Novel treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel treatments under development
Trial: 23751132
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) for 12 weeks
Trial: 19881973
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin 200 U/day + physical therapy (n = 23)
Trial: 19881973
Drug: Paracetamol 1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1,500 mg/day + physical therapy (n = 22)
Trial: 16891222
Drug: Standard nicotinamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard nicotinamide (1.2 g/m2)
Trial: 11275164
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg extended-release oxybutynin
Trial: 11275164
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg tolterodine (2 mg twice a day)
Trial: 9223394
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg bezafibrate
Trial: 8477565
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg perindopril once daily
Trial: 8477565
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg perindopril twice daily
Trial: 28430684
Drug: Flurbiprofen axetil
RxNorm normalized name: Flurbiprofen axetil
DrugBank: Flurbiprofen axetil (DB14938)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen axetil (1.5 mg/kg)
Trial: 23905378
Drug: Bushen quhan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bushen quhan zhiwang decoction (BQZD) combined with methotrexate (MTX) 10 mg/week
Trial: 23905378
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 10 mg/week alone
Trial: 10855632
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (once-daily, subcutaneous)
Trial: 10855632
Drug: Standard, continuous,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard, continuous, adjusted-dose intravenous heparin
Trial: 9115057
Drug: Intravenous fenoldopam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fenoldopam (titrated up to 0.5 microgram/kg/min)
Trial: 9115057
Drug: Intravenous fenoldopam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fenoldopam
Trial: 8327167
Drug: Forane (inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forane (inhalation anesthetic)
Trial: 8327167
Drug: Forane (inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forane (inhalation anesthetic) at higher concentration
Trial: 8327167
Drug: Intravenous anesthetic
RxNorm normalized name: Intravenous anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthetic
Trial: 3302005
Drug: Pirenzepine 50
RxNorm normalized name: pirenzepine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 50 mg twice daily
Trial: 27488081
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg twice per day
Trial: 24237751
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 10% solution once daily for 2 months
Trial: 24237751
Drug: Hydroquinone 4%
RxNorm normalized name: HYDROQUINONE 4% CREAM
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroquinone 4% solution once daily for 2 months
Trial: 20083352
Drug: Topical clonazepam
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical clonazepam
Trial: 18597830
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg once daily titrated to 100 mg once daily)
Trial: 11929471
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy and combined treatments
Trial: 9673439
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oral D‐fenfluramine
Trial: 2500718
Drug: Oral enoxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enoxacin 400 mg
Trial: 2500718
Drug: Intramuscular ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ceftriaxone 250 mg
Trial: 31373430
Drug: Lateral approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral approach injection of 40 mg/ml triamcinolone acetonide (Kenalog) and 4 ml 1% lignocaine
Trial: 31373430
Drug: Posterior approach
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior approach injection of 40 mg/ml triamcinolone acetonide (Kenalog) and 4 ml 1% lignocaine
Trial: 28701593
Drug: Dopamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine infusion at 2 μg/kg/min following anesthesia induction till the end of the surgery
Trial: 22974973
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) 1200 mg catechins, 240 mg caffeine/day for 7 days
Trial: 21375794
Drug: Hydrocortisone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (30 mg)
Trial: 21375794
Drug: Reboxetine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (4 mg) + Hydrocortisone (30 mg)
Trial: 26669965
Drug: Dianatal obstetric
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dianatal obstetric gel
Trial: 26669965
Drug: Control (labor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (labor management without obstetric gel)
Trial: 17932127
Drug: Azithromycin 1
RxNorm normalized name: azithromycin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1 g stat.
Trial: 17932127
Drug: Extended azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Extended azithromycin (500 mg on day 1 followed by 250 mg daily for 4 days)
Trial: 17932127
Drug: Extended doxycycline
RxNorm normalized name: doxycycline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended doxycycline treatment
Trial: 7741777
Drug: Slow-release propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release propafenone 2 x 225 mg
Trial: 7741777
Drug: Slow-release propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release propafenone 2 x 325 mg
Trial: 7741777
Drug: Slow-release propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release propafenone 2 x 425 mg
Trial: 7741777
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of slow-release propafenone
Trial: 1784666
Drug: Humorous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Humorous treatment (humor condition)
Trial: 29846832
Drug: Helium-neon laser
RxNorm normalized name: neon
DrugBank: Neon (DB11589)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helium-neon laser therapy (HNLT) and conventional therapy
Trial: 29846832
Drug: Infrared laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared laser therapy (ILT) and conventional therapy
Trial: 26824517
Drug: Progressive resistance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance exercise (PRE) with 0.5 kg dumbbell, performed twice a day for 8 weeks after complex decongestive physiotherapy
Trial: 24916467
Drug: EVLTAP (endovenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVLTAP (endovenous laser therapy with ambulatory phlebectomy)
Trial: 24916467
Drug: EVLA alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVLA alone with sequential phlebectomy
Trial: 7986236
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba special extract LI 1370 (Kaveri forte) 150 mg daily
Trial: 2919733
Drug: Ranitidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (50 mg every 6 hours for 72 hours)
Trial: 31243685
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg chromium
Trial: 25789270
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 2% (10 ml every 3 hours, six times a day for 6 days)
Trial: 25789270
Drug: Magic mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magic mouthwash (10 ml every 3 hours, six times a day for 6 days)
Trial: 24165976
Drug: Fedratinib (10-680
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fedratinib (10-680 mg)
Trial: 22023525
Drug: ATG 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG 7.5 mg/kg
Trial: 7721404
Drug: Irbesartan 50
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 50 mg
Trial: 9607385
Drug: Irbesartan 200
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 200 mg
Trial: 9607385
Drug: Irbesartan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (all doses > or = 50 mg)
Trial: 9607385
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 12.5 mg added to irbesartan
Trial: 352788
Drug: Prednisolone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (40 mg per day)
Trial: 30993836
Drug: BAY 81-8973
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 81-8973 low-dose prophylaxis (20-30 IU/kg twice-weekly)
Trial: 30993836
Drug: BAY 81-8973
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 81-8973 high-dose prophylaxis (30-40 IU/kg 3 times weekly)
Trial: 28255768
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 mcg)
Trial: 10420862
Drug: Physicians' ratings
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physicians' ratings of depression severity before treatment and at 6 months
Trial: 2317420
Drug: 0.5% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% plain bupivacaine 4 ml at the L2‐3 spinal interspace (n = 20)
Trial: 2317420
Drug: 0.5% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% plain bupivacaine 4 ml at the L4‐5 spinal interspace (n = 20)
Trial: 24286968
Drug: Codeine-containing cough
RxNorm normalized name: chlorpheniramine / codeine / phenylephrine Oral Solution [Endal Cough]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine-containing cough syrups (CCS) users
Trial: 20686477
Drug: Apixaban 2.5
RxNorm normalized name: apixaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban 2.5 mg twice-daily (b.i.d.)